NCNA — NuCana plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1709626 ·
Last close
$2.00
Market Cap
$8.32M
52W High
$2.33
52W Low
$1.33
ADV30
32,683
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,781,000 | -3,865,000 | 27,553,000 | 21,529,000 | 5,186,000 |
| Dec 2025 | 0 | — | -2,843,000 | -2,485,000 | 29,834,000 | 24,251,000 | 5,507,000 |
| Sep 2025 | 0 | — | -3,571,000 | -281,000 | 32,315,000 | 25,249,000 | 6,389,000 |
| Jun 2025 | 0 | — | -11,627,000 | -24,114,000 | 16,218,000 | 8,443,000 | 8,834,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,467,000
Investing CF
$159,000
Financing CF
$25,006,000
CapEx
$-193,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-100.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-252,334,000
Inventory
—
Receivables
$1,864,000
ST Investments
—
EBIT TTM
$-20,833,000
Pretax Income TTM
$-30,521,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -20,833,000 | -29,353,000 | 29,834,000 | 5,507,000 | — | -7,467,000 |
| Dec 2024 | 0 | -23,005,000 | -18,997,000 | 14,774,000 | 8,820,000 | — | -19,118,000 |
| Dec 2023 | 0 | -31,125,000 | -27,632,000 | 27,811,000 | 12,924,000 | — | -26,439,000 |
| Dec 2022 | 0 | -43,717,000 | -32,021,000 | 58,254,000 | 19,752,000 | — | -23,158,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-9.43
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals, Inc. | $8.34M | $1.94 | — |
| MCUJF | MEDICURE INC | $8.35M | $0.80 | — |
| IMRN | Immuron Ltd | $8.25M | $1.01 | — |
| ENVB | Enveric Biosciences, Inc. | $8.21M | $2.23 | — |
| GNPX | Genprex, Inc. | $8.17M | $0.77 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-05-26 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
2026-05-21 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
2026-05-19 15:27 · Yahoo
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
2026-05-18 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Down Sharply in Friday Trading
2026-05-15 15:04 · Yahoo
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 20:01 · Yahoo
European Equities Traded in the US as American Depositary Receipts Tracking Higher in Thursday Trading
2026-05-14 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading
2026-05-06 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Lower
2026-05-04 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
2026-04-27 15:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.